| Balance Sheets | 2025-09-30 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 9,098 | |||
| Investments in marketable debt securities | 143,096 | |||
| Prepaid expenses and other | 2,514 | |||
| Total current assets | 154,708 | |||
| Deposits and other | 2,684 | |||
| Right-of-use assets | 1,208 | |||
| Property and equipment, net | 64 | |||
| Total assets | 158,664 | |||
| Accounts payable | 3,259 | |||
| Compensation and benefits | 3,318 | |||
| Accrued clinical and other | 2,982 | |||
| Current portion of operating lease liabilities | 650 | |||
| Total current liabilities | 10,209 | |||
| Operating lease liabilities, net of current portion | 804 | |||
| Embedded derivative liability | 483 | |||
| Total liabilities | 11,496 | |||
| Common stock, 0.001 par value 165,000,000 shares authorized issued and outstanding 91,036,700 and 86,995,985 shares as of september 30, 2025 and june 30, 2025, respectively | 91 | |||
| Additional paid-in capital | 569,034 | |||
| Accumulated other comprehensive income (loss) | 49 | |||
| Accumulated deficit | -422,006 | |||
| Total shareholders' equity | 147,168 | |||
| Total liabilities and shareholders' equity | 158,664 | |||
Rezolute, Inc. (RZLT)
Rezolute, Inc. (RZLT)